Infant boys with a gut bacterial composition high in Bacteroidetes were found to have more advanced cognitive and language skills one year later compared to boys with lower levels of the bacteria.
Lacking confidence in our own ability may stem from overestimating the abilities and performance of others, researchers say.
A new study in Zebrafish reveals exposure to compounds found in cannabis during the early stages of development was linked to a significant drop in neural activity later in life.
Experiencing trauma or extreme stress during childhood can lead to structural changes in the hippocampus and amygdala that can be seen decades later.
Combining brain scans with AI technology, researchers were able to accurately predict the likelihood of a person developing schizophrenia in those with a family history of the psychiatric disorder.
A new intranasal delivery system shows promise in reducing neuroinflammation and slowing the progression of multiple sclerosis.
The way zebrafish respond to repeated exposure and withdrawal from nicotine mirrors more complex human responses during withdrawal.
Using a third-person, or observer, perspective to recall memories activates different areas of the brain than using a first-person perspective for memory recall. Adopting an observer-perspective for memory recall leads to increased interaction between the anterior hippocampus and posterior medial network.
A study that has been on-going for thirty-five years sheds light on several transitions throughout our lifespans.
Corticotropin-releasing factor and neuropeptide Y work in synchronized opposition to each other to remodel and rewire neurons in the amygdala as a response to stress. The process, researchers say, can be manually reversed to help relieve anxiety.
After natural killer immune cells kill virus-infected cells, T and B immune cells produce cytokines. This makes the immune reaction stronger and results in the cytokine storm associated with severe COVID-19 infection.
Remdesivir, a drug initially developed to fight Ebola and currently being fast-tracked into trials for COVID-19, is highly effective at stopping the replication mechanism of coronavirus. The drug tricks the virus by mimicking its building blocks, causing the inhibitor to get incorporated repeatedly, and preventing replication of SARS-CoV-2.
